Globus Medical (NYSE:GMED) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.950-5.050 for the period, compared to the consensus estimate of 5.000. The company also issued revenue guidance of $3.1 billion, compared to the consensus estimate of $3.2 billion.